Skip to main content
    C

    Cumberland Pharmaceuticals Inc (CPIX)

    Official site

    HEALTHCARE • DRUG MANUFACTURERS - SPECIALTY & GENERIC • NASDAQ

    $5.21
    -0.67 (-11.39%)

    Market Cap: $88.16M

    Last updated: Nov 17, 2026 at 11:03 AM ET

    Cumberland Pharmaceuticals Inc (CPIX) Valuation Multiples

    Updated Nov 17, 2026. Multiples are computed from end-of-day prices, company filings and consensus analyst estimates.

    Cumberland Pharmaceuticals (CPIX) trades at 3.1x sales and 1.1x book value. Its P/S of 3.1x is above its 5-year median of 0.9x. Its forward P/E is 50.0x.

    Current Multiples

    MultipleValue
    P/E (trailing)N/A
    Forward P/E50.0x
    Price to sales3.1x
    Price to book1.1x
    PEGN/A
    As of Nov 17, 2026

    Historical Medians

    Against its 10-year medians, its P/S is 93.8% above 1.6x and its P/B is 15.4% below 1.3x.

    MultipleCurrent5-year median10-year median
    P/S3.1x0.9x1.6x
    P/B1.1x1.0x1.3x
    Medians of month-end values through Oct 2026: 60 months (5-year) and 120 months (10-year).

    Valuation History

    Over the 10 year ends shown, its P/S ranged from 0.6x in 2023 to 3.2x in 2018.

    Year endPriceP/EP/SP/B
    2025$3.98N/A2.3x2.4x
    2024$2.37N/A0.9x1.4x
    2023$1.79N/A0.6x0.9x
    2022$2.25N/A0.8x0.9x
    2021$4.67N/A1.9x1.6x
    2020$2.9524.6x1.2x0.9x
    2019$5.1516.6x2.3x1.5x
    2018$6.03N/A3.2x1.7x
    2017$7.36N/A2.8x1.8x
    2016$5.50N/A2.7x1.2x
    Each year's multiples use the split-adjusted closing price of that year's last trading day over trailing per-share results as reported; periods with losses are left out.

    Frequently Asked Questions About CPIX

    What is CPIX's forward P/E ratio?

    Cumberland Pharmaceuticals has a forward P/E ratio of 50.0x.

    What is CPIX's price to sales ratio?

    Cumberland Pharmaceuticals has a price to sales ratio of 3.1x.